Immunosuppressive Drug Therapy in Myasthenia Gravis
- 1 February 1986
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 43 (2) , 155-156
- https://doi.org/10.1001/archneur.1986.00520020049018
Abstract
• We reviewed the records of 37 patients with myasthenia gravis treated with azathioprine (n = 10) or cyclophosphamide (n = 27). All patients had received prednisone and anticholinesterase therapy, and most had undergone thymectomy prior to immunosuppressive therapy. Thirty patients (81%) responded to treatment. Both azathioprine and cyclophosphamide were found to be effective in the treatment of myasthenia gravis. The degree of improvement was more pronounced in patients with thymoma.This publication has 4 references indexed in Scilit:
- Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseasesSeminars in Arthritis and Rheumatism, 1983
- Controversies about the treatment of myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1980
- IMMUNOSUPPRESSIVE DRUGS IN TREATMENT OF MYASTHENIA GRAVISAnnals of the New York Academy of Sciences, 1971
- The Treatment of Severe Myasthenia Gravis with Immunosuppressive AgentsEuropean Neurology, 1969